Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Imfinzi has been approved in the European Union as monotherapy for the treatment of adults with limited-stage small cell ...
Cambridge: AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in ...
BEIJING (Reuters) -Dozens of foreign CEOs will visit Beijing this month for a flagship development conference where some are ...
AstraZeneca (AZN) and Alteogen have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme platform ...
MT Newswires on MSN28m
AstraZeneca Strikes up to $1 Billion Deal to Buy EsoBiotecAstraZeneca (AZN) on Monday agreed to acquire Belgian biotechnology company EsoBiotec in a deal worth up to $1 billion as it looks to boost its cell therapies portfolio. The UK drugmaker will acquire ...
Phoenix shares surge on upgraded guidance 08:26 , Graeme Evans The FTSE 100-listed shares of ...
AstraZeneca is hopping aboard the pickleball craze as its serves up a new marketing push for its asthma med Fasenra. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback